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MISSION OF THE NHLBI      
 
The mission of the NHLBI is to provide leadership for a national program in diseases of the 
heart, blood vessels, lung, and blood; sleep disorders; and blood resources management.  The 
Institute:  
 
$ Plans, conducts, fosters, and supports an integrated and coordinated program of basic 
research, clinical investigations and trials, observational studies, and demonstration and 
education projects related to the causes, prevention, diagnosis, and treatment of heart, blood 
vessel, lung, and blood diseases and sleep disorders conducted in its own laboratories and by 
other scientific institutions and individuals supported by research grants and contracts. 
$ Plans and directs research in development, trial, and evaluation of interventions and devices 
related to prevention of diseases and the treatment and rehabilitation of patients suffering 
from such diseases and disorders. 
$ Conducts research on clinical use of blood and all aspects of the management of blood 
resources. 
$ Supports career training and development of new and established researchers in fundamental 
sciences and clinical disciplines to enable them to conduct basic and clinical research related 
to heart, blood vessel, lung, and blood diseases; sleep disorders; and blood resources through 
individual and institutional research training awards and career development awards. 
$ Coordinates relevant activities with other research institutes and all Federal health programs 
in the above areas, including the causes of stroke. 
$ Conducts educational activities, including development and dissemination of materials for 
health professionals and the public in the above areas, with emphasis on prevention. 
$ Maintains continuing relationships with institutions and professional associations, and with 
international, national, state, and local officials as well as voluntary agencies and 
organizations working in the above areas. 
$ Oversees management of the Women’s Health Initiative. 
 
 
OVERVIEW OF STRATEGY FOR ADDRESSING HEALTH DISPARITIES 
 
Throughout its history, the NHLBI has been a leader in conducting and supporting research to 
alleviate the health disparities that exist between various segments of the U.S. population, and its 
outstanding efforts in this area have been publicly recognized in Congressional hearings.  
Projects with a strong minority component have been initiated so that comparisons may be made 
between various populations.  These projects have produced a wealth of information that enable 
identification of health disparities and provide clues about their causes. 
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minorities, including high blood pressure, coronary heart disease, obesity, physical inactivity, 
diabetes, asthma, sarcoidosis, tuberculosis, sickle cell disease, and Cooley's anemia. 
 
Through its outreach and education programs, the NHLBI disseminates health-related 
information to physicians, health care professionals, patients, and the general public.  Strong 
emphasis is placed on outreach to minority populations using culturally sensitive, innovative 
approaches, such as church-based interventions to reach a large segment of the black community. 
 
The NHLBI actively recruits minority individuals into its training and career development 
programs with particular emphasis on members of racial/ethnic groups that are currently 
underrepresented in the research enterprise. 
 
Since FY 1991, the Institute has had procedures in place to ensure full compliance with the NIH 
Policy on Inclusion of Minorities and Women in Research.  As a result, all NHLBI-supported 
research that involves human subjects includes minorities, with the exception of a very few 
projects for which a strong justification for limiting the diversity of the study population exists. 
 
 
AREAS OF EMPHASIS 
 
The NHLBI has identified three Areas of Emphasis for addressing health disparities: 
(1) Research, (2) Research Workforce and Research Resources, and (3) Outreach and Education. 
The three Areas of Emphasis, components of a coordinated and interdependent effort to reduce 
and eliminate health disparities, are of equal priority in the plan. 
 
Discussions with representatives of the scientific community, healthcare-related organizations, 
and the general public are an integral part of the NHLBI planning process in all areas of 
emphasis.  As an initial step in developing new initiatives, the NHLBI holds working groups and 
workshops to assess the needs and opportunities in a research area.  The Institute's Board of 
Extramural Advisors (BEA) and the National Heart, Lung, and Blood Advisory Council 
(NHLBAC) provide continual guidance and review.  (The BEA is a working group of the 
Council, consisting of scientists of significant stature in the cardiovascular, lung, blood, and 
sleep research communities, that is charged with evaluating the NHLBI research and training 
portfolios on an ongoing basis.)  New initiatives and ongoing programs are discussed with public 
interest organizations at annual meetings; in addition, the FYI from the NHLBI, a collection of 
articles and information produced three times a year in response to the needs expressed by public 
interest organizations, includes a “constituents’ corner” where input from the public is 
welcomed. 
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In addition, research programs that focus exclusively on minority health issues have been given 
high priority.  They address diseases, conditions, and risk factors that disproportionately affect 
I.  Research 
 
Some diseases of the heart, lung, and blood occur primarily in minorities; other diseases develop, 
progress, and react to treatment differently in minorities than in whites.  For example, sickle cell 
disease (SCD) affects approximately 72,000 people in the U.S., most of whom trace their 
ancestry to Africa.  The disease occurs in about 1 of every 500 black births.  Tremendous 
progress has been made since NHLBI-supported research programs began about 30 years ago.  
Patients with sickle cell anemia now live longer on average; and care is more coordinated, 
beginning with screening of newborns, provision of appropriate control of infections, and 
prevention of stroke in high-risk children through transfusion therapy.  Yet no universal cures are 
currently available.  For example, the drug hydroxyurea, that reduces the rate of painful crises in 
SCD, is effective in only 2/3 of patients, and is largely ineffective for the related disease, 
Cooley’s anemia.  Continued progress can be expected from further studies in areas of ongoing 
research, such as bone marrow transplantation in children with SCD, expansion of use of 
hydroxyurea from adults to children, and long-term management of children with SCD who are 
receiving chronic transfusions. 
 
In several other major disease areas under the purview of the NHLBI, certain racial/ethnic 
minority groups are disproportionately affected.  A major example is cardiovascular disease 
(CVD) and its risk factors.  Recent data show that heart disease mortality is 20 percent higher in 
black males than in white males and 31 percent higher in black females than in white females, 
and the prevalence of stroke is higher in blacks than in whites at all ages.  High blood pressure, a 
risk factor for CVD, tends to be more common, develops at an earlier age, and is more severe for 
blacks than whites in the U.S.  Two other risk factors for CVD-- of physical activity and obesity-
- particularly problematic for minority populations. 
 
Asthma is a chronic lung condition that disproportionately affects children, minorities, and low-
income individuals.  New data show continuing increases in asthma-related hospitalizations, 
emergency department visits, and deaths, especially among minority populations.  Since 1979-82, 
the average age-adjusted asthma death rate for blacks has increased 71 percent compared to 41 
percent for whites, and in 1995-1998, it was almost three times that of whites.  In 1997-99, 
hospitalization rates were more than three times higher for blacks than for whites.  The cost of 
asthma in 2000 was estimated to be $12.7 billion, with direct costs amounting to $8.1 billion and 
lost earnings due to illness and death totaling $4.6 billion. 
 
Minority and lower socioeconomic populations encounter multiple barriers (e.g., financial 
constraints, logistical and cultural barriers, and environmental stressors) when attempting to 
follow health and treatment recommendations.  Development of effective interventions for 
improving adherence to medical and lifestyle regimens for these underserved groups is needed so 
that the full benefits of medical advances in the treatment of heart, lung, and blood diseases and 
sleep disorders can be realized for all segments of the U.S. population. 
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Objectives: 
 
The NHLBI has identified three main objectives within the Research area of emphasis:  
 
$ Support research to increase understanding of the development and progression of heart, 
lung, and blood diseases and sleep disorders that contribute to health disparities. 
$ Support research to develop new or improved approaches for diagnosing and treating heart, 
lung, and blood diseases and sleep disorders that contribute to health disparities.   
$ Support research to develop new or improved approaches for preventing or delaying the onset 
or progression of heart, lung, and blood diseases and sleep disorders that contribute to health 
disparities. 
 
The three objectives are of equal priority.  
 
The process for taking public comments into account in developing these objectives is the same 
as the process described above for developing areas of emphasis. 
 
A.  Support research to increase understanding of the development and progression of 
heart, lung, and blood diseases and sleep disorders that contribute to health disparities.  
 
Emphasis is on identifying genetic and environmental factors that influence development and 
progression of diseases that disproportionately affect minorities; determining mechanisms 
responsible for the progression of such diseases; and clarifying processes by which 
environmental, developmental, and psychosocial factors early in life contribute to health 
disparities later in life. 
 
Action Plan: 
 
(1) Steps to Achieve Objective 
 
The NHLBI will continue to support ongoing research programs that address this objective.  
In addition, as applications for research that focus on this objective are received, and as new 
initiatives are developed, additional research grants will be awarded. 
 
Current Major Programs  
 
Epidemiological Studies 
 
Multi-Ethnic Study of Atherosclerosis: Investigates the prevalence, correlates, and 
progression of subclinical cardiovascular disease (i.e., disease detected noninvasively before 
it has produced clinical signs and symptoms), in a population consisting of 40 percent whites, 
30 percent blacks, 20 percent Hispanics, and 10 percent Asians.   
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Early Natural History of Arteriosclerosis: Examines the association between risk factor 
development and the evolution of atherosclerosis and hypertension in a childhood population 
that has now reached adulthood; 36 percent of the participants are black. 
 
Coronary Artery Risk Development in Young Adults (CARDIA): Determines the evolution of 
coronary heart disease (CHD) risk factors and subclinical atherosclerosis in young adults; 
50 percent of the participants are black. 
 
Atherosclerosis Risk in Communities (ARIC): Investigates the association of CHD risk factors 
with development of atherosclerosis in an adult population; 27 percent of the participants are 
black. 
 
Cardiovascular Health Study (CHS): Examines risk factors for CHD and stroke in the 
elderly; 15 percent of the participants are black. 
 
Strong Heart Study: Compares risk factor levels and morbidity and mortality from 
cardiovascular disease (CVD) among American Indians in three different geographic 
locations. 
 
Genetics of Coronary Artery Disease in Alaskan Natives (GOCADAN): Documents CVD and 
CVD risk factors in approximately 40 extended families (family members from villages in 
Northern Alaska).   
 
Jackson Heart Study: Identifies environmental and genetic factors influencing the evolution 
and progression of CVD in blacks. 
 
National Longitudinal Mortality Study (NLMS) - Follow-up: Analyzes socioeconomic, 
demographic, and occupational differences in mortality in the U.S. among 1.4 million people. 
 
High Blood Pressure 
 
Molecular Genetics of Hypertension: Determines the etiology and pathogenesis of 
hypertension in order to improve diagnosis and treatment of the disease.  Among the basic 
and clinical subprojects is one that targets blacks exclusively. 
 
Family Blood Pressure Program: Establishes a collaborative network to identify major genes 
associated with high blood pressure; 66 percent of the participants are minority. 
  
Ischemic Heart Disease 
 
Specialized Centers of Research (SCOR) on Ischemic Heart Disease in Blacks: Elucidates the 
pathophysiological basis for excess morbidity and mortality from ischemic heart disease in 
blacks, and subsequently develops therapeutic strategies to address these problems.  
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Diabetes 
 
Glucose Tolerance and Risk for Cardiovascular Disease in the Elderly: Examines the 
longitudinal relationship between impaired glucose tolerance, insulin resistance, CVD risk 
factors, and CVD among Japanese American men. 
  
Insulin Resistance and Atherosclerosis Study (IRAS) Family Study: Identifies the genetic 
determinants of insulin resistance and visceral adiposity and determines the extent to which 
insulin resistance, visceral adiposity, and metabolic cardiovascular disease risk factors share 
common genetic influences; participants are black and Hispanic. 
 
Asthma 
 
Collaborative Studies on the Genetics of Asthma: Seeks to identify genes associated with 
asthma and to elucidate their functional role in the development of the disorder; 58 percent of 
the participants are minority. 
 
New Initiatives 
 
Genetic Modifiers of Single Gene Defect Diseases: Identify and characterize the modifier 
genes responsible for variation in clinical progression and outcome of sickle cell disease and 
other heart, lung, and blood diseases due to single-gene defects.  
 
Susceptibility to Target Organ Damage in High Blood Pressure: Identify genetic and other 
biological factors that increase the susceptibility to hypertension-related injury and damage to 
target organs.  Explore differences in prevalence and disease intensity among different ethnic 
groups. 
 
Severe Asthma Research Program: Establish a collaborative program to investigate the 
mechanistic basis for severe asthma and how it differs from mild-to-moderate asthma.   
 
Genetic Aspects of Tuberculosis in the Lung: Investigate the genetic aspects of tuberculosis, 
using advances in molecular biology and genomics research.  
  
(2) Timeline for Objective 
 
Current Major Programs      Renewal Likely 
Expected end date of 2002: 
 
Early Natural History of Arteriosclerosis     Yes 
 
Glucose Tolerance and Risk for Cardiovascular Disease in the Elderly Yes 
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Collaborative Studies on the Genetics of Asthma                                          Yes
Expected end date of 2003: 
 
Coronary Artery Risk Development in Young Adults (CARDIA)  Yes 
 
Expected end date of 2004: 
 National Longitudinal Mortality Study (NLMS) - Follow up  Yes 
 Insulin Resistance and Atherosclerosis Study (IRAS) Family Study Yes 
 Expected end date of 2005: 
 
Cardiovascular Health Study       Yes 
 
Strong Heart Study        Yes 
 
Genetics of Coronary Artery Disease in Alaskan Natives   Yes 
 
Jackson Heart Study        Yes 
 
Molecular Genetics of Hypertension      No 
 
Family Blood Pressure Program      Yes 
 
SCOR  on Ischemic Heart Disease in Blacks     No 
 
Expected end date of 2006 or beyond: 
 
Multi-Ethnic Study of Atherosclerosis (MESA)    No 
 
Atherosclerosis Risk in Communities (ARIC)    No 
 
New Initiatives 
 
Expected end date of 2004: 
 
Susceptibility to Target Organ Damage in High Blood Pressure 
 
Expected end date of 2005: 
 
Severe Asthma Research Program 
 
Genetic Aspects of Tuberculosis in the Lung  
 
Genetic Modifiers of Single Gene Defect Diseases 
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(3) This objective is ongoing.  See previous section for dates by which specific activities 
      within this objective are expected to be completed.  The “Renewal Likely” column (in
previous section) indicates if an activity is expected to be renewed at the completion of its  
current award period. 
 
Performance Measures:    
 
To assess performance of the NHLBI portfolio of current activities that “support research to 
increase understanding of the development and progression of heart, lung, and blood diseases 
and sleep disorders that contribute to health disparities,” NHLBI scientific staff track and 
assess the success of Institute-supported investigators in publishing articles related to this 
objective in peer-reviewed, high-quality scientific journals.  Another measure of the 
performance of ongoing research is whether the grant is renewed once its initial period of 
support ends.  Applications for competing renewal grants are reviewed carefully by peer 
reviewers and the National Heart, Lung, and Blood Advisory Council for past performance 
and published results, as well as future potential. 
 
In addition, the NHLBI portfolio is assessed frequently to ensure that it addresses newly 
identified scientific needs and opportunities.  New initiatives are developed with input from 
the scientific and healthcare-related communities and the general public, and reviewed by the 
Institute’s Board of Extramural Advisors and the National Heart, Lung, and Blood Advisory 
Council before being announced. 
 
Outcome Measures: 
 
A measure of the outcome of NHLBI-supported activities to “support research to increase 
understanding of the development and progression of heart, lung, and blood diseases and 
sleep disorders that contribute to health disparities” is the publication in peer-reviewed, high-
quality scientific journals of articles reporting science advances based on the results of   
NHLBI-supported research toward this objective.  NHLBI scientific staff continually assess 
Institute objectives and research programs in terms of the results reported in such articles.  In 
fact, as part of its annual submission to the NIH Government Performance and Review Act 
(GPRA) report, the NHLBI has consistently included several journal articles that report 
science advances pertaining to this objective based on Institute-supported research.  For 
example, in an article published in the American Journal of Human Genetics in 2001 and 
recently submitted to the NIH GPRA report, NHLBI-supported researchers reported 
identifying a link between ethnicity and “asthma genes.”  In another article published in the 
Proceedings of the National Academy of Science in 2000 and also submitted to the NIH 
GPRA report, researchers reported a possible explanation for the high levels of hypertension 
found in blacks in the U.S.  
 
B. Develop new or improved approaches for diagnosing and treating heart, lung, and 
blood diseases and sleep disorders that contribute to health disparities. 
 
Emphasis is placed on understanding differences in disease presentation in subsegments of the 
population; achieving accurate and timely diagnosis of diseases; predicting the likely clinical 
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course of disease in individuals; establishing the effectiveness, safety, and cost-effectiveness of 
treatments; and identifying and overcoming barriers to full utilization of existing knowledge 
about proven therapies. 
 
Action Plan: 
 
(1) Steps to Achieve Objective 
 
The NHLBI will continue to support ongoing research programs that address this objective.  
In addition, as new initiatives are developed that focus on this objective, additional research 
grants will be awarded. 
 
Current Major Programs 
 
High Blood Pressure 
 
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): 
Compares the combined incidence of fatal CHD and nonfatal myocardial infarction (MI) 
among patients receiving angiotensin converting enzyme (ACE) inhibitors, calcium 
antagonists, or alpha-1-blockers and patients in a control group receiving a diuretic, and in a 
subset, determines whether cholesterol-lowering therapy reduces all-cause mortality in 
moderately hypercholesterolemic individuals compared with a control group; 32 percent of 
the participants are black and 19 percent are Hispanic. 
 
PREMIER: Lifestyle Interventions for Blood Pressure Control: Compares the effectiveness 
of two multicomponent lifestyle interventions (reduced salt intake, increase physical activity, 
moderation of alcohol intake, and weight loss)--where one of the interventions also includes 
the DASH diet--on blood pressure control; 40 percent of the participants are black. 
 
Coronary Heart Disease 
 
Enhancing Recovery in Coronary Heart Disease (ENRICHD): Determines the effects of 
psychosocial interventions on morbidity and mortality in post-MI patients who are depressed 
and socially isolated, and/or who perceive themselves as lacking support from family and 
friends; 35 percent of the participants are minority. 
 
Diabetes 
 
Action to Control Cardiovascular Risk in Diabetes (ACCORD): Evaluates the benefits of 
different therapies to reduce cardiovascular complications in Type 2 diabetes; 33 percent of 
the participants are minority. 
 
 
 
 9 
      Bypass Angioplasty Revascularization Investigation in Type 2 Diabetics (BARI 2D): 
      
       
     
 
Asthma 
 
Asthma Clinical Research Network: Establishes an interactive network of asthma clinical 
research groups to conduct studies of novel therapies for asthma and disseminate findings to 
the practicing community.  The sites include Harlem Hospital, which serves a predominately 
minority population. 
 
Childhood Asthma Management Program (CAMP): Evaluates the long-term effects of 
regular use of either of two types of anti-inflammatory medications on lung growth and 
development, physical growth and development, and asthma outcomes in asthmatic children; 
26 percent of the participants are minority. 
 
Childhood Asthma Research and Education Network (CARE): Establishes an interactive 
network of clinical research groups to evaluate current and novel therapies and management 
strategies for children with asthma.  Investigators will recruit a large minority population into 
the program. 
 
Sickle Cell Disease 
 
Comprehensive Sickle Cell Centers Program: Supports coordination of resources, facilities, 
and personnel to expedite development and application of new knowledge for improved 
diagnosis and treatment of sickle cell disease and prevention of its complications.  In the 
2003-2008 funding cycle, the program will include, for the first time, a clinical research 
network component to provide for rapid evaluation of promising new treatments for sickle 
cell disease.   
 
Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG): Evaluates the efficacy and 
safety of hydroxyurea treatment in infants with sickle cell disease. 
 
Cooley's Anemia 
 
Thalassemia (Cooley's Anemia) Clinical Research Network: Accelerates research in the 
management of thalassemia, standardizes existing treatments, and evaluates new ones in a 
network of clinical centers.  Emphasis is on clinical trials that help identify optimal therapy. 
 
New Initiatives 
 
Overcoming Barriers to Treatment Adherence in Minorities and Persons Living in Poverty:  
Target clinical care settings to evaluate interventions to improve adherence to medically 
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 Evaluates various treatments for Type 2 diabetic patients with angiographically proven
coronary artery disease and stable angina or ischemia; 20 percent of the participants are
 minority
Transactivation of Fetal Hemoglobin Genes for Treatment of Sickle Cell Disease and 
Cooley’s Anemia:  Identify transactivator proteins that regulate the expression of fetal globin 
chains. 
 
Trials Assessing Innovative Strategies to Improve Clinical Practice through Guidelines: 
Investigate reasons for inadequate use of standard clinical practice guidelines for heart, lung, 
and blood diseases, particularly in treatment for racial and ethnic minorities, women, and the 
elderly; evaluate remedial interventions. 
 
Chemical Screens for New Inducers of Fetal Hemoglobin for Treatment of Sickle Cell 
Disease and Cooley’s Anemia: Develop better drugs to treat sickle cell disease and Cooley’s 
Anemia. (SBIR) 
 
(2) Timeline for Objective 
  
Current Major Programs 
 
Renewal Likely 
 
Expected end date of 2003: 
 
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart 
Attack Trial (ALLHAT)  
 
 
No 
 
PREMIER: Lifestyle Interventions for Blood Pressure Control 
 
No 
 
Enhancing Recovery in Coronary Heart Disease (ENRICHD) 
 
No 
 
Asthma Clinical Research Network 
 
Yes 
 
Comprehensive Sickle Cell Centers Program 
 
Yes 
 
Expected end date of 2004: 
 
Childhood Asthma Management Program (CAMP) 
 
No 
 
Childhood Asthma Research and Education Network (CARE) 
 
Yes 
 
Expected end date of 2005: 
 
Thalassemia (Cooley's Anemia) Clinical Research Network 
 
Yes 
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prescribed lifestyles and regimens used to treat heart, lung, blood or sleep diseases, disorders 
or conditions, cancer, or diabetes.  The populations targeted are racial and ethnic minorities 
and/or persons living in poverty. 
 
New Initiatives 
 
Expected end date of 2004: 
 
Overcoming Barriers to Treatment Adherence in Minorities and Persons Living in 
Poverty 
 
Transactivation of Fetal Hemoglobin Genes for Treatment of Sickle Cell Disease and 
Cooley’s Anemia 
 
Expected end date of 2006: 
 
Trials Assessing Innovative Strategies to Improve Clinical Practice through Guidelines 
 
SBIR (no specific expected end date): 
 
Chemical Screens for New Inducers of Fetal Hemoglobin for Treatment of Sickle Cell 
Disease and Cooley’s Anemia 
 (3) This objective is ongoing.  See previous section for dates by which specific activities 
within this objective are expected to be completed.  The “Renewal Likely” column (in 
previous section) indicates if an activity is expected to be renewed at the completion of 
its current award period. 
 Performance Measures:    
 
To assess performance of the NHLBI portfolio of current activities that “support research to 
develop new or improved approaches for diagnosing and treating heart, lung, and blood 
diseases and sleep disorders that contribute to health disparities,” NHLBI scientific staff track
and assess the success of Institute-supported investigators in publishing articles related to this
objective in peer-reviewed, high-quality scientific journals.  Another measure of the 
performance of ongoing research is whether the grant is renewed once its initial period of 
support ends.  Applications for competing renewal grants are reviewed carefully by peer 
reviewers and the National Heart, Lung, and Blood Advisory Council for past performance 
and published results, as well as future potential. 
 In addition, the NHLBI portfolio is assessed frequently to ensure that it addresses newly 
identified scientific needs and opportunities.  New initiatives are developed with input from 
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Expected end date of 2006 or beyond: 
 
Action to Control Cardiovascular Risk in Diabetes (ACCORD) 
 
No 
 
Bypass Angioplasty Revascularization Investigation in Type 2 
Diabetics (BARI 2D) 
 
 
No 
 
Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) 
 
No 
 
 
 
Outcome Measures: 
 
A measure of the outcome of NHLBI-supported activities to “support research to develop 
new or improved approaches for diagnosing and treating heart, lung, and blood diseases and 
sleep disorders that contribute to health disparities” is the publication in peer-reviewed, high-
quality scientific journals of articles reporting science advances based on the results of   
NHLBI-supported research toward this objective.  NHLBI scientific staff continually assess 
Institute objectives and research programs in terms of the results reported in such articles.  In 
fact, as part of its annual submission to the NIH Government Performance and Review Act 
(GPRA) report, the NHLBI has consistently included several journal articles that report 
science advances pertaining to this objective based on Institute-supported research.  For 
example, in an article recently published in the New England Journal of Medicine and 
submitted to the NIH GPRA report, NHLBI-supported researchers reported results showing 
inhaled corticosteroids to be safe and effective for children with asthma.  In another article 
recently  published in the British Journal of Haematology and also submitted to the NIH 
GPRA report, investigators reported that arginine supplements may benefit patients with 
sickle cell disease.  
 
C.  Develop new or improved approaches for preventing or delaying the onset or 
      progression of heart, lung, and blood diseases and sleep disorders that contribute to health 
      disparities. 
 
Abundant evidence exists that many diseases can be forestalled or prevented entirely through 
appropriate medical regimens (e.g., blood pressure control, cholesterol lowering) or through 
healthy lifestyles (e.g., prudent diet, abstinence from smoking, physical activity). Research is 
needed to identify and test approaches that can be used successfully in minority populations.     
 
Action Plan: 
 
(1) Steps to Achieve Objective 
 
The NHLBI will continue to support ongoing research programs that address this objective.  
In addition, as new initiatives are developed that focus on this objective, additional research 
grants will be awarded. 
 
Current Major Programs 
 
Girls Health Enrichment Multi-Site Studies (GEMS): Tests effectiveness of weight-control 
interventions (involving diet, physical activity, and psychosocial and familial influences) 
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the scientific and healthcare-related communities and the general public, and reviewed by the
Institute’s Board of Extramural Advisors and the National Heart, Lung, and Blood Advisory 
Council before being announced.
Tuberculosis Academic Award: Seeks to improve prevention, management, and control of 
TB by increasing opportunities for health-care practitioners to learn modern principles and 
practices by promoting coordinated clinical approaches to the care of patients of various 
ethnic groups who have TB; raising awareness among health-care providers of unique ethnic, 
cultural, and socioeconomic dimensions of TB; focusing educational efforts in areas where 
TB incidence is persistently high (e.g., immigrant communities, refugee centers, homeless 
shelters, correctional facilities); promoting development of minority faculty capable of 
providing appropriate instruction in diagnosis and management of TB; and enhancing TB 
education programs in minority medical schools and in the communities they serve. 
 
Trial of Activity for Adolescent Girls (TAAG): Tests the effectiveness of a coordinated school 
and community-based multicomponent intervention that provides skills-building, supportive 
environments, and opportunities for participation in physical activity during and outside of 
the school day to prevent the decline in physical activity levels and cardiopulmonary fitness 
of middle-school-aged girls from a wide range of racial/ethnic/socioeconomic backgrounds. 
 
Nutrient Database for American Indian and Alaska Native Foods: Establishes a set of 
comprehensive, high quality databases on the nutrient content of traditional foods and other 
foods commonly eaten by American Indians and Alaska Natives. 
 
New Initiative 
 
Centers for Reducing Asthma Disparities:  Establish cooperative centers of research to study 
asthma disparities in relation to prevalence, emergency department use, hospitalizations, and 
mortality between the general white population and minority and economically disadvantaged 
      populations. 
 
      (2) Timeline for Objective 
 
 
Current Major Programs 
 
Renewal Likely 
 
Expected end date of 2002: 
 
Girls Health Enrichment Multi-Site Studies (GEMS) 
 
No 
 
Intervention to Improve Asthma Management and Prevention at 
School 
 
 
No 
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administered during the critical transition period from prepuberty to puberty in black girls at 
 
 
Intervention to Improve Asthma Management and Prevention at School: Develops and 
 
 
high risk for obesity.
evaluates innovative programs to ensure optimal asthma management and prevention at
school; 90 percent of the participants are black
New Initiative 
 
Expected end date of 2006: 
 
Centers for Reducing Asthma Disparities 
 
(3)  This objective is ongoing.  See previous section for dates by which specific activities 
within this objective are expected to be completed.  The “Renewal Likely” column (in 
previous section) indicates if an activity is expected to be renewed at the completion of its 
current award period. 
 
Performance Measures:    
 
To assess performance of the NHLBI portfolio of current activities that “support research to 
develop new or improved approaches for preventing or delaying the onset or progression of  
heart, lung, and blood diseases and sleep disorders that contribute to health disparities,” 
NHLBI scientific staff track and assess the success of Institute-supported investigators in 
publishing articles related to this objective in peer-reviewed, high-quality scientific journals. 
Another measure of the performance of ongoing research is whether the grant is renewed 
once its initial period of support ends.  Applications for competing renewal grants are 
reviewed carefully by peer reviewers and the National Heart, Lung, and Blood Advisory 
Council for past performance and published results, as well as future potential. 
 
In addition, the NHLBI portfolio is assessed frequently to ensure that it addresses newly 
identified scientific needs and opportunities.  New initiatives are developed with input from 
the scientific and healthcare-related communities and the general public, and reviewed by the 
Institute’s Board of Extramural Advisors and the National Heart, Lung, and Blood Advisory 
Council before being announced.   
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Expected end date of 2004: 
 
Nutrient Database for American Indian and Alaska Native Foods 
 
No 
 
Expected end date of 2006 or beyond: 
 
Tuberculosis Academic Award 
 
Yes 
 
Trial of Activity for Adolescent Girls (TAAG) 
 
No 
  
Outcome Measures:  
 
A measure of the outcome of NHLBI-supported activities to “support research to develop 
     
       
        
 new or improved approaches for proventing or delaying the onset or progression of heart,
lung, and blood diseases and sleep disorders that contribute to health disparities is the
publication in peer-reviewed, high-quality scientific journals of articles reporting science
 
advances based on the results of NHLBI-supported research toward this objective.  NHLBI 
scientific staff continually assess Institute objectives and research programs in terms of the 
results reported in such articles.  In fact, as part of its annual submission to the NIH 
Government Performance and Review Act (GPRA) report, the NHLBI has consistently 
included several journal articles that report science advances pertaining to this objective 
based on Institute-supported research.  For example, in an article appearing in The Lancet and 
submitted to the NIH GPRA report, researchers present findings that suggest that exposure to 
allergens early in life may prevent a lifetime of allergic asthma, a finding that argues against
current theories.  In another article published in Blood in 2000 and also submitted to the NIH 
GPRA report, researchers reported finding that elevated levels of a certain enzyme in the 
blood are associated with development of pulmonary complications from sickle cell disease.
If these results are confirmed by larger clinical trials, enzyme measurements could be used to
identify patients with impending pulmonary complications, thereby allowing treatment to be
initiated before the complications develop. 
 
II.  Research Workforce and Research Resources 
 
For many years, the NHLBI has been particularly concerned with increasing the participation of 
minority individuals in biomedical research careers.  Continuing development of research 
workforce and research resources remains a high priority with the NHLBI.  The Institute adheres 
to the premise that increasing the number of highly trained minority individuals whose basic or 
clinical research interests are in cardiovascular, lung, and blood diseases and sleep disorders and 
improving the research infrastructure at minority institutions are crucial elements in eliminating 
health disparities.   
 
These activities are extremely important to the elimination of health disparities because it has 
been demonstrated that participation of minority investigators in the biomedical research 
enterprise has several positive effects: it improves the recruitment and retention rates of 
minorities in population-based research studies; it encourages more minority students to pursue 
careers in the biomedical and behavioral sciences because they have role models and potential 
mentors with whom they can identify; it improves access to health care because minority 
clinicians tend to establish practices in minority communities; and it adds to the body of 
knowledge about diseases that have a disproportionate impact on minorities, because minority 
investigators tend to pursue research related to minority populations. 
 
Objective: 
 
Expand the opportunities in research training and career development for 
underrepresented minorities. 
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The NHLBI emphasizes increasing the number of highly trained minority investigators through 
  
 
 
support of a range of programs designed to help investigators develop research careers.  The
general aim of these programs is to help minority investigators develop research careers through
participation in research relevant to the institute’s mission and through a process of mentoring by
 
established investigators.  The NHLBI also fosters collaborative partnerships between research-
   
 
Action Plan: 
 
(1) Steps to Achieve Objective 
 
Current Major Programs 
 
Historically Black Colleges and Universities (HBCU) Research Scientist Award: Provides an 
opportunity for HBCUs offering the master's, Ph.D., or professional degrees to recruit 
established scientists to help expand their research base and to train students in and expose 
them to the latest scientific advances.  The NHLBI will offer the Research Scientist Award 
for Minority Institutions in FY 2002 to extend this award to all institutions with a student 
enrollment that is greater than 50 percent members of cultural or racial minority groups. 
 
NHLBI Mentored Development Award for Minority Faculty: Provides support to 
underrepresented minority faculty members, with varying levels of research experience, to 
prepare them for research careers in cardiovascular, pulmonary, hematologic, and sleep 
disorders. 
 
Biomedical Research Training Program for Underrepresented Minorities: Provides minority 
undergraduate, graduate, and health professional students majoring in the life sciences an 
opportunity to receive training in the NHLBI intramural laboratories. 
 
NHLBI Minority Institution Research Scientist Development Award: Provides research 
support to faculty members at minority institutions who have the interest and potential to 
conduct high-quality research in the areas of cardiovascular, pulmonary, hematologic, and 
sleep disorders; enhances the institution's science infrastructure; and provides "hands-on" 
research opportunities for minority students enrolled at the applicant institutions. 
 
NHLBI Minority Institutional Research Training Program: Supports training of graduate and 
health professional students and individuals in postdoctoral training at minority schools who 
have the potential to develop meritorious training programs in cardiovascular, pulmonary, 
hematologic, and sleep disorders. 
 
NHLBI MARC Summer Research Training Program: Offers honor students participating in 
the Minority Access to Research Careers Undergraduate Student Training in Academic 
Research (MARC U*STAR) program a 10-week summer research experience in the NHLBI 
intramural laboratories. 
 
      Short-term Training for Minority Students Program: Provides short-term research support to 
      underrepresented minority undergraduate and graduate students and students in health    
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intensive and minority-serving institutions.
 
professional schools to expose them to career opportunities in cardiovascular, pulmonary, 
hematologic, and sleep disorders research. 
 
Research Supplements for Underrepresented Minorities (NIH wide): Provides support for 
research experiences for minorities throughout the continuum from high school to the faculty 
level to increase the number of underrepresented minority scientists participating in 
biomedical research and the health related sciences and to establish a diversified workforce. 
 
Minority Biomedical Research Support Program (NIH wide): Offers opportunities for 
underrepresented minority undergraduate and graduate students to receive training in 
fundamental biomedical sciences and clinical research disciplines in order to enhance career 
opportunities in biomedical research, including clinical and laboratory medicine, 
epidemiology, and biostatistics as applied to the etiology and treatment of heart, blood vessel, 
lung, and blood health and diseases, and sleep disorders.  
 
New Initiative 
 
Minority Undergraduate Biomedical Education Program: Supports the development of pilot 
programs that will encourage minority institutions to recruit and retain talented undergraduate 
students into the biomedical and behavioral sciences. 
 
(2) Timeline for Objective 
  
Current Major Programs 
 
Expected end date of 2006 or beyond (ongoing programs - renewal likely): 
 
HBCU Research Scientist Award / Research Scientist Award for Minority Institutions 
 
NHLBI  Mentored Development Award for Minority Faculty 
 
Biomedical Research Training Program for Underrepresented Minorities 
 
NHLBI Minority Institution Research Scientist Development Award 
 
NHLBI Minority Institutional Research Training Program 
 
NHLBI MARC Summer Research Training Program 
 
Short-Term Training for Minority Students Program 
 
Research Supplements for Underrepresented Minorities (NIH wide) 
 
Minority Biomedical Research Support Program (NIH wide) 
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New Initiative 
 
Expected end date of 2005: 
 
Minority Undergraduate Biomedical Education Program 
 
(3) This objective is an ongoing effort by the NHLBI that is being addressed through the 
programs listed. 
 
Performance Measures: 
 
The NHLBI has consistently, over the years, increased its funding commitment for these 
programs and continues to add new programs.  The Institute closely scrutinizes the programs 
to ensure that institutions and mentors alike meet the needs of minority investigators thereby 
providing minority researchers with opportunities to further their scientific training and 
achieve their research career goals.  Applications to these programs are carefully evaluated to 
make sure the proposed training meets the needs of the minority trainee and the Institute.  
Only those applications considered to be of sufficiently high enough quality to provide an 
exceptional training experience are considered.  In addition, the NHLBI takes into account an 
institution’s or mentor’s track record of providing a positive training experience when 
considering whether to make an award. 
 
Outcome Measures: 
 
The number of minority investigators participating in these NHLBI-sponsored training 
opportunities continues to increase.  The NHLBI has also added new programs that have 
expanded the opportunities for underrepresented minorities to develop a career in the 
biomedical sciences.  The Institute also continues to measure the progress of training 
experiences through required progress reports.  While the true outcome of these programs 
may not be fully appreciated for years, already it is evident that an increasing number of 
underrepresented minority individuals are using these programs to help build their careers in 
biomedical research, often by entering a program while undergraduates and receiving training up 
into the doctoral, postdoctoral, and investigator levels of research. 
III.  Outreach and Education  
A major feature of the NHLBI’s efforts to increase the quality and years of Americans' healthy 
life and to end racial and ethnic disparities in the burden of disease is the use of outreach and 
education.  The NHLBI understands that a key factor to achieving better health is access to 
information, especially relevant, culturally sensitive materials that aid individuals in making 
healthy choices.  The Institute’s interest in this area encompasses not only the behavior of 
patients and the general public, but also the behavior of health care providers who dispense 
advice and prescribe medications.  
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Expand and strengthen our programs of outreach and education for minority populations. 
 
National education programs of the NHLBI have been very successful in increasing public 
awareness and control of hypertension and high blood cholesterol, for example.  However, 
further progress is still needed, especially in certain vulnerable subsets of the population.  To 
address this issue, the NHLBI recently established Enhanced Dissemination and Utilization 
Centers (EDUCs) as a means of extending the health benefits associated with current clinical 
guidelines and medical information.  Six EDUCs have been established in communities at high 
risk for cardiovascular disease.  They are using information generated by the Institute's education 
programs to inform their communities of the public health burdens of cardiovascular disease and 
to develop, implement, and evaluate educational strategies to reduce the burden.  The Institute 
believes this new approach will provide a solid foundation for our efforts to address Healthy 
People 2010 performance objectives of eliminating racial/ethnic and geographic disparities in 
underserved high-risk populations. 
 
Action Plan: 
 
(1) Steps to Achieve Objective 
 
Current Major Programs 
 
Salud para su Corazón: This project is dedicated to improving cardiovascular health among 
Hispanics.  It has developed a wide variety of materials that provide a rich source of 
information on heart-health interventions for consumers, program planners, community 
leaders, and lay health workers.  Through partnerships and collaborations, this program 
educates local communities in linguistically and culturally appropriate ways. 
 
Strengthening the Heartbeat of American Indian/Alaska Native Communities: This project is 
developing culturally appropriate materials to encourage behavior changes that will improve 
cardiovascular health in native American populations, working collaboratively with the 
Indian Health Service and local tribal communities, villages, and pueblos. 
Asian American and Pacific Islander (AAPI) ASPIRE Project: This project is a 
cardiovascular community outreach program for Asian Americans and Pacific Islanders 
(AAPIs).  It has gained support and interest from community-based organizations, churches, 
and health centers in different parts of the country, as a result of national dissemination of 
two reports focusing on the toll of heart disease on AAPIs.  
National Physicians’ Network Project: This project provides continuing education 
opportunities and other information to clinicians and other health professionals who provide 
health care to blacks.     
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Objective: 
 
Cardiovascular Disease Enhanced Dissemination and Utilization Centers (EDUCs): The 
NHLBI has established a partnership with six community-based organizations (EDUCs) as 
part of a nationwide strategy to develop a network of partners to promote community-based 
cardiovascular health in high-risk populations.  The six EDUCs are located in rural 
communities with heart disease and stroke death rates far in excess of the national average. 
 
Asthma Coalition Network Awards: The National Asthma Education and Prevention Program 
(NAEPP) established a decade ago, is strongly committed to reducing and ultimately 
eliminating disparities in asthma preventive health care, diagnosis and treatment, and 
morbidity and mortality.  In FY 2000, it awarded contracts to seven local asthma coalitions to 
implement interventions to improve asthma control in high-risk communities.  These projects 
target low-socioeconomic strata, minority populations, and children who are 
disproportionately affected by asthma.  They involve a number of strategic partnerships with 
a broad base of community groups, and use new information technologies to facilitate 
effective transfer of the current science base to practitioners. 
 
Women’s Heart Health Education Initiative: This health education effort aims to reduce 
death and disability from cardiovascular disease in women.  The objectives of a recent 
planning workshop were to: 1) develop goals for the women’s heart health education effort; 
2) identify the primary target audiences; 3) identify the needs of minority target audiences 
who are at greater risk for cardiovascular disease; and 4) develop programmatic 
recommendations as well as methods for implementation and dissemination. 
 
(2) Timeline for Objective 
  
Current Major Programs 
 
Renewal Likely 
 
Expected end date of 2002: 
 
National Physicians’ Network Project 
 
Yes 
 
Expected end date of 2003: 
 
Asthma Coalition Network Awards 
 
Yes 
 
Expected end date of 2004: 
 
Cardiovascular Disease Enhanced Dissemination and Utilization 
Centers (EDUCs) 
 
 
Yes 
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Keeping Hearts Alive: This project works with community organizations and leaders to 
promote cardiovascular health in blacks in Washington, D.C., and Baltimore, Maryland.  
NHLBI will develop educational materials aimed at black communities. 
Keeping Hearts Alive Yes 
 
NHLBI Women’s Heart Health Education Initiative 
 
Yes 
 
(3) The objective to improve and expand our outreach and education efforts directed toward 
underrepresented minorities is an ongoing effort. 
 
Performance Measures: 
 
The NHLBI consistently seeks to develop new ways to reach and educate the general public 
and to find appropriate ways to reach out to minority populations.  The Institute frequently 
reviews the progress of its current outreach programs and works closely with its advisory 
council to develop and implement new programs.  This process of evaluation, development, 
and review led to development of the new EDUCs program. 
 
Although women’s health issues have long been addressed by NHLBI national education 
programs, the Institute is developing a new initiative focused specifically on educating the 
public and health care professionals about women’s heart health. The goal is to reduce death 
and disability in women by increasing awareness and dispelling misinformation about heart 
disease risk in women, improving the way health professionals detect and treat cardiovascular 
disease risk factors in women, reaching minority women who are at increased risk of 
developing cardiovascular disease, and motivating communities to make greater use of 
resources already available at the local level.  
 
Another example of the NHLBI’s commitment to evaluating community needs and 
developing relevant programs is creation of the “Star Sleeper” campaign, with Garfield, the 
comic strip cat, as a means to get the message out to elementary school children that a good 
night’s rest is important to their health. 
 
 
 
 
Outcome Measures: 
 
The NHLBI points to the increased public awareness of the need to control hypertension and 
to lower blood cholesterol as evidence that its outreach programs are working, but the 
Institute understands that much more needs to be done.  Clearly, the results of some of these 
programs may not be fully realized for years to come, since they are ongoing efforts to 
modify public behavior and attitudes related to health.  The Institute remains committed to 
seek out new opportunities to get its message out to the public, and to develop new programs 
to meet the special needs of minorities in order to better alleviate health disparities.  
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Expected end date of 2006 or beyond: 
 
Salud para su Corazón 
 
Yes 
 
Strengthening the Heartbeat of American Indian/Alaska Native 
Communities 
 
 
Yes 
 
Asian American and Pacific Islander (AAPI) ASPIRE Project 
 
Yes 
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   NHLBI Health Disparities Budget   
   (Dollars in Millions)   
        
        
FY 2002 FY 2003 
Institute / Center Research Infrastructure Outreach Research Infrastructure Outreach 
NHLBI $208.00 $28.80 $3.20 $223.20 $30.20 $3.40 
 
